← Open Payments lookup

MELISSA CUMMINS: Open Payments

NPI 1275196651 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$438 in 22 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $817 · 2025 $438

Food & beverage: $438
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$123
Axsome Therapeutics, Inc.3$61
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$56
ABBVIE INC.3$54
Takeda Pharmaceuticals U.S.A., Inc.2$34
Sage Therapeutics, LLC1$30
Otsuka America Pharmaceutical, Inc.1$25
Corium, LLC2$20
Luye Pharma (USA) Ltd.1$19
Alkermes, Inc.1$16

Products named: HETLIOZ, Auvelity, CAPLYTA, VRAYLAR, TRINTELLIX, ZURZUVAE, ABILIFY MAINTENA, Azstarys.

Industry payments across MI — which companies pay providers there.